First Republic Investment Management Inc. grew its position in shares of POINT Biopharma Global Inc. (NASDAQ:PNT – Free Report) by 33.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 20,000 shares of the company’s stock after buying an additional 5,000 shares during the […]
/PRNewswire/ Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential.
POINT Biopharma Global (NASDAQ:PNT – Get Free Report)‘s stock had its “neutral” rating reiterated by equities researchers at Piper Sandler in a research report issued to clients and investors on Tuesday, Benzinga reports. They presently have a $12.50 price objective on the stock. Piper Sandler’s target price suggests a potential downside of 2.19% from the […]
NEW YORK, Oct. 18, 2023 /PRNewswire/ Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or.